Results 231 to 240 of about 3,440,112 (288)

Targeting Inflammation in Obesity and the Cardiovascular-Kidney-Metabolic Syndrome Spectrum: A Narrative Review. [PDF]

Obes Facts
Noormandi A, Bugger H, Aziz F, Milicevic Z, von Lewinski D, Ludvik B, Parzer V, Zirlik A, Pieber TR, Dimai HP, Sourij H.   +10 more
europepmc   +1 more source

The potential for biased signalling in the P2Y receptor family of GPCRs

British Journal of Pharmacology, EarlyView.
The purinergic receptor family is primarily activated by nucleotides, and contains members of both the G protein coupled‐receptor (GPCR) superfamily (P1 and P2Y) and ligand‐gated ion channels (P2X). The P2Y receptors are widely expressed in the human body, and given the ubiquitous nature of nucleotides, purinergic signalling is involved with a plethora
Claudia M. Sisk, Simon Pitchford, Graham Ladds   +2 more
wiley   +1 more source

Editorial: Community series in: cardiovascular risks in cardiovascular-kidney-metabolic syndrome: mechanisms and therapies, volume II. [PDF]

Front Endocrinol (Lausanne)
Zhou R, Zhang B, Wang W, Piao J, Ma W.
europepmc   +1 more source

Novel approaches for drug development against chronic primary pain: A systematic review

British Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus, Éva Borbély, Andreas Goebel, Ralf Baron, Zsófia Hajna, Zsuzsanna Helyes   +5 more
wiley   +1 more source

Short- and long-term associations of insulin resistance indices with cardiovascular-kidney-metabolic syndrome risk: a retrospective cohort study. [PDF]

Front Endocrinol (Lausanne)
Luo H, Wang X, Zhang C, He J, Sun M, Yang Y, Wang M, Hu R, Xiao S, Chen Z, Shu C, Yin X.   +11 more
europepmc   +1 more source

Preventing Cardiovascular-Kidney-Metabolic Syndrome Progression: Pharmacologic Approaches and Pharmacists' Contributions.

Cardiorenal Med
Nguyen T, Hong L, Iso T.
europepmc   +1 more source

Visceral adiposity and cardiovascular risk in the era of cardiovascular-kidney-metabolic syndrome. [PDF]

Am J Prev Cardiol
Kokkorakis M, Oikonomou EK.
europepmc   +1 more source

Global Burden of Key Components of Cardiovascular-Kidney-Metabolic Syndrome Among Women of Reproductive Age, 1990-2021. [PDF]

J Evid Based Med
Jiang C, Qiu J, Wei C, Zhou E, Zhu H, Huang W, Zhou T, Hu J.   +7 more
europepmc   +1 more source

GlycA-gene interactions in cardiovascular-kidney-metabolic syndrome: evidence from genetic association. [PDF]

Diabetol Metab Syndr
Yuan M, Cao S, Wan X, Yang Y, Fan S, Xie J, Wang H.   +6 more
europepmc   +1 more source